Paracetamol Baxter Healthcare (Paracetamol)

Paracetamol works by inhibiting central cyclooxygenase enzymes, particularly COX‑3, which reduces the synthesis of prostaglandins involved in pain signaling and fever generation. It also influences serotonergic pathways and the endogenous cannabinoid system, contributing to its central analgesic effect without significant peripheral anti‑inflammatory activity.

The appropriate dose of Paracetamol Baxter Healthcare is determined by the prescribing clinician based on the patient’s age, weight, clinical condition, and hepatic function. Healthcare professionals calculate the exact infusion volume and rate to achieve the desired therapeutic effect while adhering to safety guidelines.

Paracetamol is generally considered the analgesic/antipyretic of choice when treatment is required during pregnancy or lactation, but its use should be limited to situations where the benefit outweighs any potential risk. The prescriber should evaluate each case individually and follow local regulatory guidance.

To order Paracetamol Baxter Healthcare, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will request trade or institutional credentials. The sales team then provides pricing, availability, shipping details (including cold‑chain logistics if needed), and assists with import documentation.

Compared with non‑steroidal anti‑inflammatory drugs (NSAIDs) such as ibuprofen, intravenous paracetamol offers effective pain relief and fever reduction without the gastrointestinal or platelet‑inhibiting effects typical of NSAIDs. It is also less likely to cause renal impairment in short‑term use, making it a preferred choice for patients at risk of bleeding or with gastric ulcer disease.

Paracetamol Baxter Healthcare should be stored at 2‑8 °C, protected from light, and kept in its original packaging. Do not freeze or shake the solution. Before administration, inspect the vial for particulate matter or discoloration and allow it to reach room temperature if required by the infusion protocol.

The product is supplied as a sterile intravenous solution that is administered by slow infusion through a peripheral or central venous line. The infusion rate and total volume are set by the healthcare professional according to the prescribed dose, patient weight, and clinical condition, ensuring safe and effective delivery.

The most serious risks include severe hepatic injury, which can be life‑threatening, and rare hypersensitivity reactions such as anaphylaxis or Stevens‑Johnson syndrome. Patients should be monitored for signs of liver dysfunction, rash, or respiratory compromise, especially if they have pre‑existing liver disease or are taking other hepatotoxic agents.

Paracetamol Baxter Healthcare should be avoided in individuals with known hypersensitivity to paracetamol or any of the formulation excipients. It is also contraindicated in patients with severe hepatic impairment, active liver disease, or in those who have experienced serious adverse reactions to paracetamol in the past.